Lobbying disclosures · Lobbying report
ABT: third_quarter 2026 lobbying report
Proposals related to digital health technologies and innovations. Proposals to support colorectal screening coverage for veterans. Proposals regarding the creation of quality measures for colorectal cancer screening. Proposals related to the use of diagnostic tests in CLIA-waived settings. Proposals related to VA coverage of continuous glucose monitors. Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to the competitive bidding process. Proposals related to The RAPID (Regulatory Alignment for Predictable and Immediate Device) coverage pathway initiative
Follow ABT- Became public
- Oct 20, 2026, 5:05 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 9:48 AM EST
Why this is connected
Exact legal-name match: ABBOTT LABORATORIES (https://www.sec.gov/Archives/edgar/data/1800/).
Reported lobbying amounts
Expenses: $1,300,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/1c6f9c6c-e8db-4dd1-bc8b-52de65fa21f9/","filing_uuid":"1c6f9c6c-e8db-4dd1-bc8b-52de65fa21f9","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/1c6f9c6c-e8db-4dd1-bc8b-52de65fa21f9/print/","filing_document_content_type":"text/html","income":null,"expenses":"1300000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Seth Radus","dt_posted":"2026-10-20T17:05:39-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1801 PENNSYLVANIA AVENUE, NW","registrant_address_2":"SUITE 900","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":66,"url":"https://lda.gov/api/v1/registrants/66/","house_registrant_id":30001,"name":"ABBOTT LABORATORIES","description":null,"address_1":"1801 PENNSYLVANIA AVENUE, NW","address_2":"SUITE 900","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SETH RADUS","contact_telephone":"+1 202-378-2020","dt_updated":"2026-07-26T15:03:24.712043-04:00"},"client":{"id":100021,"url":"https://lda.gov/api/v1/clients/100021/","client_id":12,"name":"ABBOTT LABORATORIES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Proposals related to digital health technologies and innovations. Proposals to support colorectal screening coverage for veterans. Proposals regarding the creation of quality measures for colorectal cancer screening. Proposals related to the use of diagnostic tests in CLIA-waived settings. Proposals related to VA coverage of continuous glucose monitors.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68934,"prefix":null,"prefix_display":null,"first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149748,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152699,"prefix":null,"prefix_display":null,"first_name":"LYNN","nickname":null,"middle_name":null,"last_name":"SHA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":132,"name":"Agency for Healthcare Research & Quality (AHRQ)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to the competitive bidding process. Proposals related to The RAPID (Regulatory Alignment for Predictable and Immediate Device) coverage pathway initiative for eligible Breakthrough Medical Devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152699,"prefix":null,"prefix_display":null,"first_name":"LYNN","nickname":null,"middle_name":null,"last_name":"SHA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68934,"prefix":null,"prefix_display":null,"first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proposals related to U.S. global health programs and pandemic preparedness.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Proposals related to third party litigation reform.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOO","general_issue_code_display":"Food Industry (safety, labeling, etc.)","description":"H.R.2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula. Initiatives to support patient access to therapeutic nutrition. Proposals regarding the implementation and modernization of the WIC program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149748,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"S.2003 The Strengthening Benefit Plans Act of 2025. S.4784 The National Defense Authorization Act of 2027. Proposals related to pension premiums and employee benefits.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149748,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Proposals related to data privacy/data collection, usage and retention.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149748,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Proposals related to the Agriculture and Nutrition Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149748,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in ABT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Abbott Laboratories ABT
$1K–$15K · Traded Sep 17, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 27, 2026$50K–$100K
Rep. Pete Sessions (R-TX-17)
$50K–$100K · Traded Oct 2, 2026 · disclosed Oct 27, 2026 · Spouse
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 18, 2026 · disclosed Oct 12, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 18, 2026$15K–$50K
Rep. Rick W. Allen (R-GA-12)
$15K–$50K · Traded Jul 14, 2026 · disclosed Aug 18, 2026 · Spouse
Committee overlap: Energy and CommerceTraded 2 days before earnings - Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
Got $2K from the company’s PAC - Aug 12, 2026$1K–$15K
Rep. Mike Kelly (R-PA-16)
$1K–$15K · Traded Jul 17, 2026 · disclosed Aug 12, 2026 · Spouse
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
Sold (full) Abbott Laboratories ABT
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.